HOX Therapeutics is focused on developing novel treatments for cancer.
Our lead programme is a dual inhibitor of the androgen receptor and is designed to treat patients insensitive to current drugs for castration resistant prostate cancer. Our second programme targets the Hox-PBX interaction; Hox is switched on in solid and haematological tumours.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Thame
- Industry
- Biotechnology
- Website
- http://www.hoxtherapeutics.com/
- HQ
- Thame
Hox Therapeutics Ltd Questions
Hox Therapeutics Ltd's website is http://www.hoxtherapeutics.com/
Hox Therapeutics Ltd's LinkedIn profile is https://uk.linkedin.com/company/hox-therapeutics-limited
Hox Therapeutics Ltd has
4 employees.
View email and phone details for 4
employees at Hox Therapeutics Ltd.
Hox Therapeutics Ltd's industry is
Biotechnology
Hox Therapeutics Ltd's top competitors are
Gigabiome,
Aila Biotech Ltd,
Simplex Molecular,
Redx Pharma,
Sonobac, Inc.,
Xgenera,
Immupharma Plc,
Betaglue Therapeutics,
Bugbiome,
Almac Group.
Hox Therapeutics Ltd's categories are Biotechnology
Hox Therapeutics Ltd's founding year is 2016
